Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This finding does not suggest that HIV treatment will be any less effective at keeping people healthy or preventing transmission.
Canadian researchers analyzed the reasons why people declined a nurse’s offer of PrEP.
More widespread vaccination could reduce cervical, anal, oral and other cancers caused by human papillomavirus.
Researchers surveyed HIV-positive women age 50 and older and compared their reports about their aging with those of HIV-negative women.
A study found evidence that antiretroviral treatment does not necessarily restore T cells’ memories of vaccines and past infections.
Researchers analyzed more than 350 studies to estimate the prevalence of hepatitis B among people with HIV around the world.
Researchers in London assessed a program to train nurses to provide routine HIV testing in general practice clinics.
Both Truvada and Descovy are highly effective and safe for most people taking PrEP, but the newer option has more cost barriers.
A study of people at high risk of poor outcomes assessed a program that sought to address numerous needs that may affect their health.
Researchers infected 1-month-old primates with HIV-like virus and 30 hours later injected them with a pair of antibodies.
Intravenous administration allowed the marginally effective BCG vaccination to work better in monkeys.
Central to the overall strategy is a greater focus on public health processes that help deliver testing and treatment to those in need.
Between 2006 and 2015, the estimated time between contracting the virus and starting antiretrovirals declined by 42%.
This vitamin treatment has previously been well established as safe and effective for people without the virus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.